IRS
Wondering what the smart money is up to? These hedge fund investor letters will point you in the right direction. We’ve got investor letters from leading and emerging managers around the globe, so you’ll always be up to date on what the smart money is doing.
Some of the top hedge managers whose investor letters we cover include big name funds such as Dan Loeb, David Einhorn, “The Big Short” Greg Lippmann, Jeffrey Ubben’s ValueAct Capital, Marc Azer’s Two Sigma; as well as top emerging managers such as Alluvial Fund, Grey Owl Capital, Arquitos Capital, L1 Capital, Khrom Capital, Black Bear Value Fund, Kernow Asset Management, Gator Capital.
NOTE: We are not affiliated with nor do we endorse any funds listed.
Stay on top of the latest in hedge fund commentary below.
If you would like to see your fund covered please email us at info(@)hedgefundalpha.com. All inquires are confidental. We do not charge any money to cover funds. We only cover those funds who we think are interesting, add value or the like (although we do not endorse any fund or investing). All emails are confidential and your investors will not know you sent us your letter.
While we prefer prominent fund managers and top emerging fund managers we will accept other genres. However, your vehicle must be legally registered with FINRA (and if applicable the SEC) or your local equivalent (like the FCA in the UK to be considered.
Also see our hedge fund database tool here.
Tony Ward President, Americas, at Xero On Small Business And The Effects Of Covid-19
JAM Partners’ Favorite Deep Value Financial Plays [2020 Letter]
David Einhorn: The 3 Types Of Valuation Indifferent Investors
Mohnish Pabrai: 6.5x Return On Deep Value Turkish Stock [2020 Letter]
Blue Eagle Capital Partners: Long Thesis For This Lending Stock
Q4 2020 Sortable Hedge Fund Letters Database: Greenlight, Baupost, Loeb, Tiger Global, Maverick, Millennium And MUCH More
4 Economic Challenges for 2021
The Stock Market Snowball
David Einhorn’s Greenlight had a strong fourth quarter; Gains on Neubase Therapeutics [Full Q4 Letter]
Value Investing Parallels: The Late 1990s And Now
After 10.1% Return In 2020, Mohnish Pabrai Changes Strategy [2020 Letter]
Exclusive: Saba Capital Announces New SPAC Opportunities Fund
Eric Cinnamond: Absolute Return Small Cap Value Management And Silver
Oh, Quality, Where Art Thou?
The Price is Right With Dimensional Fund Advisors’
Value Briefs
We’re Going to Need More Than a Vaccine
International Value with Distillate Capital’s Thomas Cole
Opportunities In SPACs

